Published in Hum Genet on August 24, 2010
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am (2011) 1.45
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci U S A (2013) 1.38
Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability. J Clin Invest (2014) 1.12
Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women. Hum Reprod (2011) 1.12
MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability. Am J Hum Genet (2014) 1.04
The ageing ovary and uterus: new biological insights. Hum Reprod Update (2012) 1.04
Intraovarian control of early folliculogenesis. Endocr Rev (2014) 0.99
Genomic markers of ovarian reserve. Semin Reprod Med (2013) 0.94
Genetic variation and reproductive timing: African American women from the Population Architecture using Genomics and Epidemiology (PAGE) Study. PLoS One (2013) 0.93
DNA methylome and transcriptome sequencing in human ovarian granulosa cells links age-related changes in gene expression to gene body methylation and 3'-end GC density. Oncotarget (2015) 0.89
A chromosome 19 locus positively influences the number of retrieved oocytes during stimulated cycles in Brazilian women. J Assist Reprod Genet (2012) 0.89
Meta-analysis of loci associated with age at natural menopause in African-American women. Hum Mol Genet (2014) 0.88
ESR1, HK3 and BRSK1 gene variants are associated with both age at natural menopause and premature ovarian failure. Orphanet J Rare Dis (2012) 0.86
Genome-wide association study of age at menarche in African-American women. Hum Mol Genet (2013) 0.85
Genome wide association study of age at menarche in the Japanese population. PLoS One (2013) 0.85
Pharmacogenetics of follicle-stimulating hormone action. Curr Opin Endocrinol Diabetes Obes (2012) 0.85
Investigating the role of X chromosome breakpoints in premature ovarian failure. Mol Cytogenet (2012) 0.83
Genetics of the first seven proprotein convertase enzymes in health and disease. Curr Genomics (2013) 0.82
Analysis of LIN28A in early human ovary development and as a candidate gene for primary ovarian insufficiency. Mol Cell Endocrinol (2012) 0.82
Evaluating GWAS-identified SNPs for age at natural menopause among chinese women. PLoS One (2013) 0.81
Identification of breast cancer prognosis markers using integrative sparse boosting. Methods Inf Med (2012) 0.79
A microsatellite polymorphism in IGF1 gene promoter and timing of natural menopause in Caucasian women. Int J Med Sci (2015) 0.77
Genetics of the ovarian reserve. Front Genet (2015) 0.76
c-JUN Dimerization Protein 2 (JDP2) Is a Transcriptional Repressor of Follicle-stimulating Hormone β (FSHβ) and Is Required for Preventing Premature Reproductive Senescence in Female Mice. J Biol Chem (2016) 0.75
Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors. Menopause (2017) 0.75
Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk. Front Oncol (2017) 0.75
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Population structure and eigenanalysis. PLoS Genet (2006) 37.21
Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet (1999) 23.67
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry (2007) 7.00
ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics (2010) 6.46
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev (2002) 5.34
A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol (2008) 5.07
Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin Chem (2007) 4.45
Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet (2008) 4.31
Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol (1987) 3.77
The variability of female reproductive ageing. Hum Reprod Update (2002) 3.52
Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember? Am J Epidemiol (2002) 3.11
Genetic variation in LIN28B is associated with the timing of puberty. Nat Genet (2009) 3.09
Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet (2009) 3.06
Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat Genet (2009) 2.58
Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche. Nat Genet (2009) 2.58
Once and again-issues surrounding replication in genetic association studies. J Clin Endocrinol Metab (2002) 2.35
Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab (1998) 2.27
Age at menopause as a risk factor for cardiovascular mortality. Lancet (1996) 1.94
Common genetic influences on BMI and age at menarche. Hum Biol (1995) 1.93
The role of genetic factors in age at natural menopause. Hum Reprod (2001) 1.83
Association studies of common variants in 10 hypogonadotropic hypogonadism genes with age at menarche. J Clin Endocrinol Metab (2008) 1.83
Heritability of age at natural menopause in the Framingham Heart Study. J Clin Endocrinol Metab (2005) 1.80
Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet (2009) 1.72
Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab (1999) 1.67
Age at menarche as a fitness trait: nonadditive genetic variance detected in a large twin sample. Am J Hum Genet (1990) 1.60
Implications of the FMR1 gene in menopause: study of 147 Spanish women. Menopause (2001) 1.58
Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet (2006) 1.53
Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res (1992) 1.47
Female sex hormones, salt, and blood pressure regulation. Am J Hypertens (2004) 1.33
Early menopause, number of reproductive years, and bone mineral density in postmenopausal women. Am J Public Health (1993) 1.30
Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai. Int J Cancer (2004) 1.29
Association of polymorphisms of the oestrogen receptor alpha gene with the age of menarche. Hum Reprod (2002) 1.23
Genomewide linkage scan for quantitative trait loci underlying variation in age at menarche. J Clin Endocrinol Metab (2006) 1.16
A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod (2007) 1.12
Relation of early menarche to high bone mineral density. Calcif Tissue Int (1995) 1.11
Genetic basis of human female pelvic morphology: a twin study. Am J Phys Anthropol (2002) 1.11
Estimating genetic influences on the age-at-menarche: a survival analysis approach. Am J Med Genet (1991) 1.09
Genome-wide linkage analysis to age at natural menopause in a community-based sample: the Framingham Heart Study. Fertil Steril (2005) 1.08
Reproductive factors in breast cancer epidemiology. Acta Oncol (1992) 1.07
Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age. Am J Hum Genet (2004) 1.04
Weight-adjusted genome scan analysis for mapping quantitative trait Loci for menarchal age. J Clin Endocrinol Metab (2006) 1.03
Age at menarche and breast cancer risk in nulliparous women. Breast Cancer Res Treat (1995) 1.02
Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Hum Reprod (2005) 1.02
Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab (2001) 1.02
Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females. Hum Mol Genet (2006) 1.01
Genetic influences on the age at menopause. Lancet (1998) 1.01
Polymorphism in the insulin-like growth factor 1 gene is associated with age at menarche in caucasian females. Hum Reprod (2007) 0.98
Association study of the oestrogen signalling pathway genes in relation to age at natural menopause. J Genet (2007) 0.95
The oestrogen receptor alpha gene is linked and/or associated with age of menarche in different ethnic groups. J Med Genet (2005) 0.95
Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. J Clin Endocrinol Metab (2003) 0.94
No association of estrogen receptor alpha and cytochrome P450c17alpha polymorphisms with age at menopause in a Dutch cohort. Hum Reprod (2004) 0.94
CYP gene polymorphisms and early menarche. Mol Genet Metab (2001) 0.93
Chromosomal regions 22q13 and 3p25 may harbor quantitative trait loci influencing both age at menarche and bone mineral density. Hum Genet (2008) 0.91
Association of SHBG gene polymorphism with menarche. Mol Hum Reprod (2005) 0.90
Combined estrogen receptor alpha and estrogen receptor beta genotypes influence the age of menarche. Hum Reprod (2005) 0.90
The chemokine (C-C-motif) receptor 3 (CCR3) gene is linked and associated with age at menarche in Caucasian females. Hum Genet (2006) 0.89
Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition. Menopause (2008) 0.89
Polymorphisms associated with thrombophilia and vascular homeostasis and the timing of menarche and menopause in 728 white women. Menopause (2005) 0.87
Predictive factors for age at menopause in Caucasian females. Maturitas (2005) 0.87
The age of menarche. ORGYN (1995) 0.87
Hypothesis testing: proportions. Circulation (2006) 0.86
Estrogen receptor alpha gene polymorphisms and bone mineral density in healthy children and young adults. Calcif Tissue Int (2004) 0.85
Polymorphisms of the CYP1B1 gene may be associated with the onset of natural menopause in Chinese women. Maturitas (2006) 0.84
Predictive factors for early menarche in Taiwan. J Formos Med Assoc (1997) 0.84
Factor V Leiden mutation accelerates the onset of natural menopause. Menopause (2003) 0.83
Menopause and cardiovascular disease. J Psychosom Obstet Gynaecol (1997) 0.82
Apolipoprotein E genotype and age at menopause. Ann N Y Acad Sci (2004) 0.80
A polymorphism of the Nos3 gene and age at natural menopause. Fertil Steril (2002) 0.78
The influence of Nos3 polymorphisms on age at menarche and natural menopause. Maturitas (2004) 0.76
Finding the missing heritability of complex diseases. Nature (2009) 67.95
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
Inflammation and atherosclerosis. Circulation (2002) 20.77
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst (2004) 19.00
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet (2008) 16.25
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Replicating genotype-phenotype associations. Nature (2007) 16.11
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68
Progress and challenges in translating the biology of atherosclerosis. Nature (2011) 9.41
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med (2008) 8.40
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med (2009) 7.62
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32
Genetic risk prediction--are we there yet? N Engl J Med (2009) 7.30
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet (2009) 6.79
Powerful SNP-set analysis for case-control genome-wide association studies. Am J Hum Genet (2010) 6.60
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16
Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol (2009) 6.11
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol (2004) 6.08
Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med (2009) 6.00
Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med (2007) 5.95
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79